| Application no. and date | 05015454.1 (espacenet) (Federated) (European Patent Register), 20020529 | | Patent/reg. no. and date | DK/EP 1666481, 20120919 | | Publication date | 20060607 | | Priority no. and date | US 294775 P, 20010531, US 341048 P, 20011206 | | EP pub. no. and date |
EP 1666481 20060607 | | Effective date | | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton, CT 06340, US | | Applicant ref. no. | P81204156DK00E | | Inventor | Koecher, Christian, Weizacker 17
1717 St Ursen, CH,
Vries, Ton, Troelstralaan 56
9722 JM Groningen, NL,
Wilcox, Glenn Ernest,
Pfizer Global Rsearch, & Develop
Eastern Point Rd
Groton
Connecticut 06340, US,
Flanagan, Mark Edwards,
Pfizer Global Rsearch, & Develop
Eastern Point Rd
Groton
Connecticut 06340, US,
Munchhof, Michael John,
Pfizer Global Rsearch, & Develop
Eastern Point Rd
Groton
Connecticut 06340, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61P 37/06 (2006.01) , C07D 211/56 (2006.01) , C07D 487/04 (2006.01) | | Title | 3-((3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitril som proteinkinase inhibitor | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2017 00035 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
